Samara Asset Group Valuation

Is SRAG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SRAG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SRAG's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SRAG's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SRAG?

Key metric: As SRAG is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SRAG. This is calculated by dividing SRAG's market cap by their current revenue.
What is SRAG's PS Ratio?
PS Ratio	11.2x
Sales	€9.84m
Market Cap	€110.23m

SRAG key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	14x
Enterprise Value/EBITDA	-41.5x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does SRAG's PS Ratio compare to its peers?

The above table shows the PS ratio for SRAG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	7.5x
A7A Heliad	21.9x	-171.4%	€77.8m
LQAG Laiqon	3.4x	22.3%	€100.9m
NF4 Netfonds	0.5x	10.9%	€91.7m
EFS3 Effecten-Spiegel	4.2x	n/a	€48.0m
SRAG Samara Asset Group	11.2x	n/a	€110.2m

Price-To-Sales vs Peers: SRAG is expensive based on its Price-To-Sales Ratio (11.2x) compared to the peer average (7.5x).

Price to Sales Ratio vs Industry

How does SRAG's PS Ratio compare vs other companies in the DE Capital Markets Industry?

23 Companies	Price / Sales	Estimated Growth	Market Cap
MLP MLP	0.7x	2.8%	US$688.28m
AR4 AURELIUS Equity Opportunities SE KGaA	0.2x	0.01%	US$500.05m
MUX Mutares SE KGaA	0.09x	10.5%	US$483.70m
AR4 AURELIUS Equity Opportunities SE KGaA	0.1x	n/a	US$405.01m

23 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: SRAG is expensive based on its Price-To-Sales Ratio (11.2x) compared to the German Capital Markets industry average (2.8x).

Price to Sales Ratio vs Fair Ratio

What is SRAG's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SRAG PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	11.2x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate SRAG's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Yeahka

HK$4.7b

An investment holding company, provides payment and business services to merchants and consumers in the People’s Republic of China.

4YE

HK$1.30

-7.8%

-27.8%

Exor

€20.4b

Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.

EYX

€94.60

1.4%

11.1%

Schroders

UK£4.9b

A publicly owned investment manager.

PYXB

UK£3.62

-3.5%

-21.6%